SEC
SlamSEC
SearchBrowseEarnings

AVENUE THERAPEUTICS, INC.

OTC:ATXI
Pharmaceutical Preparations·BAY HARBOR ISLANDS, FL
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

Summary Financials

Revenue
—
Adj. EBITDA
—
Net Income
-$3.7M
FY 2022
EPS (Diluted)
-$0.31
FY 2021
Stock Price
—
52W Range
—
P/E Ratio
—
Market Cap
—
Cash
$1.8M
FY 2024
Total Debt
$1.8M
FY 2017
Net Debt
$43,000
FY 2017
Enterprise Value
—
Debt / EBITDA
—
EV / EBITDA
—
Employees
—